The role of CYP2C19 gene variants in the development of bleeding in patients receiving clopidogrel as part of dual antithrombotic therapy: a clinical case of a patient with coronary heart disease and atrial fibrillation after acute coronary syndrome

For citation: De V.A., Kochetkov A.I., Mirzaev K.B., Abdullaev Sh.P., Konik V.A., Ostroumova O.D., Sychev D.A. The role of CYP2C19 gene variants in the development of bleeding in patients receiving clopidogrel as part of dual antithrombotic therapy: a clinical case of a patient with coronary heart disease and atrial fibrillation after acute coronary syndrome. Clinical review for general practice. 2024; 5 (11): 49–54 (In Russ.). DOI: 10.47407/kr2024.5.11.00516

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.